Elravie Premier UD Regulatory Status: Market Access & Certifications for Professionals

Elravie Premier UD is a hyaluronic acid (HA) dermal filler produced by Huons, a prominent pharmaceutical company based in South Korea. As with other products in the Hyaluronic acid dermal filler catalog, Elravie Premier UD is designed for professional aesthetic use. Clinics and distributors globally source this product for its established presence in various aesthetic markets. Understanding the origin and manufacturer is the first step in assessing its regulatory profile.

The primary regulatory approval for Elravie Premier UD originates from its country of manufacture, South Korea. It holds KFDA approval (Korean Ministry of Food and Drug Safety), which is fundamental for its production and distribution within the domestic market.

For international market access, other certifications are often sought. Regarding the CE Mark, which is vital for legal distribution within the European Union, practitioners should verify the current status directly with their supplier. Huons has historically pursued international certifications for its products. The US FDA status for Elravie Premier UD is [VERIFY: US FDA status - currently not FDA approved for sale in the US market]. It is essential for professionals to confirm that any HA filler they acquire, such as Hyaldew, complies with the specific regulatory landscape of their operating region.

Market access for Elravie Premier UD varies significantly by region, dependent on local health authority regulations and specific product registrations.

• European Union (EU) & United Kingdom (UK): Access requires a valid CE Mark, often under the Medical Device Regulation (MDR). Absence of this makes direct import for sale problematic.
• GCC (Gulf Cooperation Council): Countries like UAE and Saudi Arabia typically require local registration with their respective health ministries (e.g., MOHAP in UAE, SFDA in KSA). This often necessitates manufacturer-backed submission.
• LATAM (Latin America): Regulations differ by country (e.g., ANVISA in Brazil, COFEPRIS in Mexico). Local registration is usually mandatory.
• APAC (Asia-Pacific): Beyond Korea, countries like Australia (TGA), Singapore (HSA), and Malaysia (MDA) have their own registration processes.

Practitioners sourcing products like LEXYAL or Elravie Premier UD must ensure their supplier can demonstrate compliance for their specific market.

Parallel importing involves sourcing products outside the manufacturer's official distribution channels. While this can sometimes present cost advantages, it introduces significant regulatory and quality risks. Professionals must be aware that products sourced through parallel imports may lack crucial documentation, warranty support, or even authenticity assurances. Ensuring legal compliance is paramount for your clinic's reputation and patient safety. Always prioritize suppliers who provide transparent regulatory documentation and direct supply chain clarity, similar to sourcing guidelines provided for other key products like Elasty Plus 1CC: A Professional Wholesale Sourcing Guide.

When sourcing Elravie Premier UD, clinics should demand comprehensive documentation from their wholesale supplier to ensure authenticity and regulatory compliance. Key documents include:

• Certificate of Origin: Verifies the product's manufacturing country.
• Certificate of Analysis (CoA): Details product specifications and quality control testing for specific batches.
• Batch/Lot Number Traceability: Essential for tracking the product's journey from manufacturer to your clinic.
• GMP (Good Manufacturing Practice) Certificate: Confirms the manufacturer adheres to quality standards.
• ISO Certifications: e.g., ISO 13485 for medical devices, indicating a robust quality management system.
• Regional Marketing Authorization/Registration: Proof of legal market access in your operating country (e.g., CE Mark for EU, local health authority registration).

Never accept vague assurances. Detailed, verifiable documentation protects your practice.

For professionals considering stocking Elravie Premier UD, an illustrative wholesale price point for a single unit is approximately $92.0. Pricing structures are typically designed with volume-tier discounts, rewarding larger orders for aesthetic clinics and wholesale buyers. These tiers might include reductions of 4% for orders of 11 units, 5% for 21 units, 6% for 31 units, and 8% for orders of 51 units or more. These structures enable clinics to manage inventory costs effectively while maintaining a steady supply of popular HA fillers.